Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.2 USD | +2.88% | +1.53% | -29.78% |
Mar. 01 | Citigroup Cuts Schrodinger Price Target to $39 From $47, Maintains Buy Rating | MT |
Mar. 01 | Goldman Sachs Cuts Schrodinger's Price Target to $26 From $29, Keeps Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.78% | 1.77B | |
+8.42% | 2,979B | |
+3.01% | 78.63B | |
+4.15% | 77.7B | |
-12.94% | 53.96B | |
-15.68% | 50.39B | |
+26.00% | 46.4B | |
+13.88% | 38.04B | |
+53.53% | 33.68B | |
-11.38% | 23.88B |
- Stock Market
- Equities
- SDGR Stock
- News Schrödinger, Inc.
- Schrödinger : University of Texas' MD Anderson, Schrodinger to Jointly Develop Anti-Cancer Treatments